The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 2004-2010

  Malyak, Mark ^a   Smith Jr , Michael F ^a   Abel, Ashley A ^a   Hance, Kenneth R ^a   Arend, William P ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSCRIPTION TERMINATION; TRANSLATION REGULATION;

CELLS, CULTURED; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRACELLULAR FLUID; ISOMERISM; LEUKOCYTES, MONONUCLEAR; MONOCYTES; NEUTROPHILS; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; SIALOGLYCOPROTEINS; SUBCELLULAR FRACTIONS;

EID: 0032529388     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dinarello, C. A. 1996. Biologic basis for interleukin-i in disease. Blood 87:2095.
2. Arend, W. P., and J.-M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and TNF α in rheumatoid arthritis. Arthritis Rheum. 38:151.
3. Lennard, A. C. 1995. Interleukin-1 receptor antagonist. Crit. Rev. Immunol. 15: 77.
4. Arend, W. P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54:167.
5. Malyak, M., R. E. Swaney, and W. P. Arend. 1993. Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: potential contribution from synovial fluid neutrophils. Arthritis Rheum. 36:781.
6. Fischer, E., K. J. Van Zee, M. A. Marano, C. S. Rock, J. S. Kenney, D. D. Poutsiaka, C. A. Dinarello, S. F. Lowry, and L. L. Moldawer. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196.
7. Firestein, G. S., D. L. Boyle, C. Yu, M. M. Paine, T. D. Whisenand, N. J. Zvaifler, and W. P. Arend. 1994. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum. 37:644.
8. Miller, L. C., E. A. Lynch, S. Isa, J. W. Logan, C. A. Dinarello, and A. C. Steere. 1993. Balance of synovial fluid IL-1/3 and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341:146.
9. Smith D. R., S. L. Kunkel, T. J. Standiford, M. W. Rolfe, J. P. Lynch III, D. A. Arenberg, C. A. Wilke, M. D. Burdick, F. J. Martinez, J. N. Hampton, R. I. Whyte, M. B. Orringer, and R. M. Stricter. 1995. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis: a compartmental analysis. Am. J. Respir. Crit. Care Med. 151:1965.
10. Chomarat, P., E. Vannier, J. Dechanet, M. C. Rissoan, J. Banchereau, C. A. Dinarello, and P. Miossec. 1995. Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J. Immunol. 154: 1432.
11. Ferretti, M., V. Casini-Raggi, T. T. Pizarro, S. P. Eisenberg, C. C. Nast, and F. Cominelli. 1994. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J. Clin. Invest. 94:449.
12. Wakabayashi, G., J. A. Gelfand, J. F. Burke, R. C. Thompson, and C. A. Dinarello. 1991. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5:338.
13. Eisenberg, S. P., R. J. Evans, W. P. Arend, E. Verderber, M. T. Brewer, C. H. Hannum, and R. C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341.
14. Haskill, S., G. Martin, L. Van Le, J. Morris, A. Peace, C. F. Bigler, G. J. Jaffe, C. Hammerberg, S. A. Sporn, S. Fong, W. P. Arend, and P. Ralph. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88:3681.
15. Malyak, M., J. M. Guthridge, K. R. Hance, S. K. Dower, J. H. Freed, and W. P. Arend. 1998. Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J. Immunol. 161:1997.
16. Butcher, C., A. Steinkasserer, S. Tejura, and A. C. Lennard. 1994. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J. Immunol. 153:701.
17. Bigler, C. F., D. A. Norris, W. L. Weston, and W. P. Arend. 1992. Interleukin-1 receptor antagonist production by human keratinocytes. J. Invest. Dermatol. 98: 38.
18. Arend, W. P., M. F. Smith, Jr., R. W. Janson, and F. G. Joslin. 1991. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J. Immunol. 147:1530.
19. Jenkins, J. K., M. Malyak, and W. P. Arend. 1994. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13:47.
20. Malyak, M., M. F. Smith, Jr., A. A. Abel, and W. P. Arend. 1994. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J. Clin. Immunol. 14:20.
21. Lord, P. C. W., L. M. G. Wilmoth, S. B. Mizel, and C. E. McCall. 1991. Expression of interleukin-1α and β genes by human blood polymorphonuclear leukocytes. J. Clin. Invest. 87:1312.
22. Re, F., M. Mengozzi, M. Muzio, C. A. Dinarello, A. Mantovani, and F. Colotta. 1993. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur. J. Immunol. 23:570.
23. Beaulieu, A. D., and S. R. McColl. 1994. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum. 37:855.
24. Muzio, M., M. Sironi, N. Polentarutti, A. Mantovani, and F. Colotta. 1994. Induction by TGF-β1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur. J. Immunol. 24:3194.
25. Muzio, M., F. Re, M. Sironi, N. Polentarutti, A. Minty, D. Caput, P. Ferrera, A. Mantovani, and F. Colotta. 1994. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83:1738.
26. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Esp. Med. 179:1695.
27. Arend, W. P., F. G. Joslin, and R. J. Massoni. 1985. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J. Immunol. 134:3868.
28. Malyak, M., F. G. Joslin, E. L. Verderber, S. P. Eisenberg, and W. P. Arend. 1991. IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors. J. Immunol. Methods 140:281.
29. Arend, W. P., M. Malyak, M. F. Smith, Jr., T. D. Whisenand, J. L. Slack, J. E. Sims, J. G. Giri, and S. K. Dower. 1994. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153:4766.
30. Arend, W. P., D. F. Gordon, W. M. Wood, R. W. Janson, F. G. Joslin, and S. Jameel. 1989. IL-1β production in cultured human monocytes is regulated at multiple levels. J. Immunol. 143:118.
31. Klempner, M. S., R. B. Mikkelsen, D. H. Corfman, and J. André-Schwartz. 1980. Neutrophil plasma membranes: high-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J. Cell Biol. 86:21.
32. Puzas, J. E., and D. B. P. Goodman. 1978. A rapid assay for cellular deoxyribonucleic acid. Anal. Biochem. 86:50.
33. Hannum, C. H., C. J. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Somner, S. P. Eisenberg, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336.
34. Maier, J. A. M., P. Voulalas, D. Roeder, and T. Maciag. 1990. Extension of the life-span of human endothelial cells by an interleukin-1 a antisense oligomer. Science 249:1570.
35. Maier, J. A. M., M. Statuto, and G. Ragnotti. 1994. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 14:1845.
36. Watson, J. M., A. K. Lofquist, C. A. Rinehart, J. C. Olsen, S. S. Makarov, D. G. Kaufman, and J. S. Haskill. 1995. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J. Immunol. 155:4467.
37. Andersson, J., L. Björk, C. A. Dinarello, H. Towbin, and U. Andersson. 1992. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur. J. Immunol. 22:2617.
38. Wahl, S. M., G. L. Costa, M. Corcoran, L. M. Wahl, and A. E. Berger. 1993. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J. Immunol. 150:3553.
39. Muzio, M., N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani, and F. Colotta. 1995. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J. Exp. Med. 182:623.